Wegovy contains semaglutide, the same main ingredient as Ozempic
Ozempic is licensed specifically for type 2 diabetes, not weight management alone
Dosing ranges from 0.25 mg to 2.4 mg weekly for semaglutide, 0.75 mg to 4.5 mg weekly for dulaglutide, and 0.6 mg to 3 mg daily for liraglutide, with your healthcare provider determining the optimal dose based on glycemic control, tolerability, renal function, and cardiovascular risk factors
Yes, it is commonly studied in laboratory models related to muscle, tendon, and tissue repair mechanisms.
Preclinical research has demonstrated that GLP-1 receptor activation may confer neuroprotective effects through multiple mechanisms
This medication can potentially lead to fluctuations in your blood sugar levels, necessitating adjustments to your dosage or other medications